CXCL8 and melanoma: Although imaging new technologies is evolving in dermatooncology [41], finding new biomarkers and/or enlarging the biomarkers panel for monitoring melanoma patients with parameters as vitamin D and IL-8 could both aid the prognosis of the disease and could identify high risk subgroups.